chr18-75427532-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001037331.3(SMIM21):c.32G>A(p.Arg11Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000134 in 1,611,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001037331.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMIM21 | ENST00000579022.5 | c.32G>A | p.Arg11Gln | missense_variant | 1/3 | 1 | NM_001037331.3 | ENSP00000462106.1 | ||
SMIM21 | ENST00000584508.1 | c.32G>A | p.Arg11Gln | missense_variant | 1/3 | 1 | ENSP00000462572.1 | |||
SMIM21 | ENST00000382638.3 | c.32G>A | p.Arg11Gln | missense_variant | 1/2 | 1 | ENSP00000372083.3 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 15AN: 151968Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000958 AC: 24AN: 250612Hom.: 0 AF XY: 0.0000960 AC XY: 13AN XY: 135458
GnomAD4 exome AF: 0.000138 AC: 201AN: 1459464Hom.: 0 Cov.: 31 AF XY: 0.000142 AC XY: 103AN XY: 726086
GnomAD4 genome AF: 0.0000987 AC: 15AN: 151968Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74234
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2024 | The c.32G>A (p.R11Q) alteration is located in exon 1 (coding exon 1) of the SMIM21 gene. This alteration results from a G to A substitution at nucleotide position 32, causing the arginine (R) at amino acid position 11 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at